课题基金 / 基金详情

项目摘要

项目成果

Brad Amendt的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our long range objective is to understand how HIV-1 regulates the levels of its gene products to optimize virus replication. One of the ways gene expression of HIV-1 is optimized is through alternative RNA splicing, a process which is necessary to produce the appropriate levels of the different HIV-1 mRNAs . Interference with HIV-1 alternative splicing may be a novel approach for antiviral therapy. The basic HIV-1 splicing pattern is conserved in all strains of HIV-1 suggesting its importance for viral replication. The efficiencies with which different splice sites are used are determined by the splice sites themselves and cis elements within the genome called exonic splicing silencers (ESS) and exonic splicing enhancers (ESE). The proposed studies are driven by our recent results indicating the crucial importance of some of the elements for virus replication. First, we will create additional mutations within splice sites and splicing elements and study their role in determining the level of expression of the viral Vif protein, a protein which acts to inactivate the antiviral cellular protein APOBEC3G, and in virus replication. Second, we will isolate nascent HIV-1 mRNA to determine at what point in the lifetime of the viral mRNA that splicing takes place-whether it is during or after RNA transcription is completed. Finally, we will study regulation of splicing of the outlier Group O viruses compared to the major Group M strains. Group O viruses appear to use different cis elements than Group M HIV-1 strains to regulate splicing. Identification of these elements may give us new insights about the evolution of HIV-1.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs.
用于剪接 HIV-1 env/nef 和 rev mRNA 的重叠顺式位点。
DOI: 10.1074/jbc.273.51.34551
发表时间: 1998
期刊: The Journal of biological chemistry
影响因子: --
作者: [Swanson,AK, Stoltzfus,CM]
通讯作者: Stoltzfus,CM
DOI: 10.1016/s0065-3527(09)74001-1
发表时间: 2009
期刊: Advances in virus research
影响因子: --
作者: [C. Stoltzfus]
通讯作者: C. Stoltzfus
Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
人类免疫缺陷病毒 1 型 tat 外显子 2 和 tat-rev 外显子 3 中存在外显子剪接沉默子:细胞因子介导抑制的证据。
DOI: 10.1128/mcb.15.8.4606
发表时间: 1995
期刊: Molecular and cellular biology
影响因子: 5.3
作者: [Amendt,BA, Si,ZH, Stoltzfus,CM]
通讯作者: Stoltzfus,CM
Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site.
通过激活隐秘剪接位点修复 Rev-minus 人类免疫缺陷病毒 1 型突变体。
DOI: 10.1128/jvi.75.7.3495-3500.2001
发表时间: 2001
期刊: Journal of virology
影响因子: 5.4
作者: [Verhoef,K, Bilodeau,PS, vanWamel,JL, Kjems,J, Stoltzfus,CM, Berkhout,B]
通讯作者: Berkhout,B
Training in Molecular Virology and Viral Pathogenesis
  • 批准号:
    7101880
  • 项目类别:
  • 资助金额:
    $10.05万
  • 财政年份:
    1998
  • 负责人:
    Brad Amendt
  • 依托单位:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
  • 批准号:
    2653779
  • 项目类别:
  • 资助金额:
    $3.91万
  • 财政年份:
    1998
  • 负责人:
    Brad Amendt
  • 依托单位:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
  • 批准号:
    6372845
  • 项目类别:
  • 资助金额:
    $7.72万
  • 财政年份:
    1998
  • 负责人:
    Brad Amendt
  • 依托单位:
TRAINING IN MOLECULAR VIROLOGY AND VIRAL PATHOGENESIS
  • 批准号:
    6169085
  • 项目类别:
  • 资助金额:
    $7.25万
  • 财政年份:
    1998
  • 负责人:
    Brad Amendt
  • 依托单位:
海外基金